AG真人官方

Grove Collaborative Holdings, Inc. (GROV) 鈥� Form 4 Insider Filing

Director John B. Replogle was granted 59,200 Restricted Stock Units (RSUs) on 10 July 2025. Each RSU represents the contingent right to receive one share of Class A common stock.

• Vesting: RSUs fully vest on the earlier of 15 May 2026 or the date of the 2026 Annual Meeting of Stockholders.
• Cost: Grant price is $0, typical for equity compensation.
• Beneficial ownership: Following the grant, the director beneficially owns 59,200 shares; no prior holdings are disclosed in this filing.
• Expiration: RSUs carry no expiration date.

The filing reflects routine board compensation rather than an open-market purchase, so the immediate cash impact and signal value are limited. However, it does modestly increase insider alignment by tying compensation to future share performance.

Aehr Test Systems (AEHR) filed a Form 4 disclosing that President & CEO Gayn Erickson had 2,489 common shares withheld on 07/11/2025 (transaction code F) at a price of $14.11 per share. The shares were automatically withheld by the issuer to cover statutory tax obligations triggered by the vesting of previously granted equity awards; no open-market sale occurred. After the withholding, Erickson retains 278,081 shares held directly and 291,088 shares held indirectly through a trust. The reported withholding represents less than 1 % of the executive鈥檚 aggregate beneficial ownership and does not signal a discretionary reduction in exposure to AEHR stock.

On July 11, 2025, Aehr Test Systems (ticker AEHR) Chief Operating Officer Adil Engineer filed a Form 4 reporting an administrative share disposition. The filing shows a Transaction Code "F," signifying that 580 common shares were automatically withheld at $14.11 each to cover tax obligations arising from the vesting of restricted stock units (RSUs). The aggregate value is roughly $8.2 thousand.

After the withholding, the executive continues to directly own 47,167 common shares, which includes unvested RSUs (as noted in footnote 2). No derivative securities were acquired or disposed of, and there were no open-market sales. Because the transaction is non-discretionary and involves a small share count relative to the officer鈥檚 total holdings, it is viewed as neutral in terms of market impact.

Aehr Test Systems (AEHR) Form 4 Filing Overview

Director Fariba Danesh reported the receipt of 9,253 shares of AEHR common stock on July 2, 2025 under a restricted stock unit (RSU) award, coded 鈥淎鈥� for acquisition at a price of $0. After the grant, Danesh directly owns 25,643 shares, a total that includes unvested RSUs. The award vests in equal one-eighth installments every three months, contingent upon continued service on the board. No derivative securities were exercised or disposed of, and no open-market transactions occurred.

The filing appears to be part of routine director compensation rather than a discretionary purchase or sale. As such, it does not signal a material shift in ownership structure or insider sentiment, but it does modestly increase the director鈥檚 equity alignment with shareholders.

Oxford Square Capital Corp. has filed a Definitive Additional Proxy Material (DEFA14A) to notify stockholders of the 2025 Annual Meeting scheduled for 9:00 a.m. ET on August 20, 2025 at the company鈥檚 headquarters in Greenwich, CT. The filing outlines the Notice & Access model, directing investors to https://www.proxy-direct.com/oxf-34572 for full proxy materials or to request paper copies by August 8, 2025. Shareholders will vote on two routine proposals:

• Election of one director鈥擝arry A. Osherow鈥攖o serve until the 2028 Annual Meeting.
• Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.

Voting can be completed online, by telephone, or via mailed proxy upon request using the provided 14-digit Control Number and 8-digit Security Code. The company reserves the right to switch to a virtual format, with any change to be announced via additional proxy materials and press release. No filing fee is required for this submission.

On 07/07/2025, FMR LLC 鈥� the parent company of Fidelity Investments 鈥� and its chair & CEO Abigail P. Johnson filed a Schedule 13G disclosing ownership of 5,600,662 common shares of Omada Health, Inc. (OMDA), corresponding to 10.0 % of the outstanding stock as of the event date 06/30/2025.

The filing indicates a passive investment under Rule 13d-1(b). FMR LLC reports sole voting power and sole dispositive power over the entire position, with no shared voting or dispositive authority. Ms. Johnson is deemed a co-reporting beneficial owner because of her control of FMR LLC; she likewise claims sole dispositive power over the same shares.

No purchase price, transaction details, or intent to influence control are provided. The signatories certify that the shares were acquired in the ordinary course of business and not in connection with any control-changing objective or proxy contest. An exhibit lists the subsidiaries through which the securities are held, but those details are not included in the text provided.

Implications for investors:

• A blue-chip institutional investor now holds a double-digit stake, which can enhance market confidence and liquidity.
• Because the filing is on Schedule 13G, FMR signals a passive stance; however, surpassing the 10 % threshold increases its potential influence in future corporate governance matters if it later opts for an active role.
• The concentration of voting rights in a single institution could also become a risk factor should Fidelity decide to trim or exit the position.

The document contains no financial statements, earnings data, or management commentary; it is strictly an ownership disclosure required by SEC rules.

Form 4 filing overview: Aehr Test Systems (AEHR) reported insider activity by Chief Technology Officer Donald P. Richmond II on 07/02/2025.

• Acquisitions (Code A): 12,161 and 1,642 common shares were acquired via the vesting of restricted stock units (RSUs). No cash was paid (price $0).
• Disposition for taxes (Code F): 221 shares were automatically withheld at $15.13 per share to satisfy tax obligations related to the RSU vesting. This was not an open-market sale.
• Post-transaction holdings: Richmond鈥檚 direct beneficial ownership rose to 216,140 common shares. The total includes unvested RSUs and 17,011 shares previously received when the company terminated its Employee Stock Ownership Plan on 04/25/2025.
• Vesting schedules: 鈥� Grant 1 鈥� 1/16th of the shares vest every three months.
  鈥� Grant 2 鈥� 25% vested immediately; the remaining 75% will vest quarterly over the next three years.

The filing indicates continuing equity-based compensation for the CTO, increasing management鈥檚 aligned stake without immediate cash outflow. The small tax-related share withholding has negligible impact on total share count.

Form 4 filing 鈥� Aehr Test Systems (AEHR) submitted 07/03/2025 discloses insider transactions by Vernon Rogers, Executive Vice President of Sales & Marketing.

• 13,351 common shares (Transaction Code A) were acquired on 07/02/2025 through restricted stock unit (RSU) vesting at $0 cost. Footnote 1 states 1/16 of the award vests every three months.
• An additional 1,614 common shares (Code A) vested on the same date at $0 cost; 25% of this award vested immediately, with the remainder vesting quarterly over three years (Footnote 2).
• 218 shares (Code F) were withheld at $15.13 per share to satisfy tax-withholding obligations (Footnote 3); this is not an open-market sale.
• After all transactions, Mr. Rogers directly owns 70,390 AEHR shares, which include unvested RSUs (Footnote 4). The filing notes he previously received 6,486 shares upon termination of the company鈥檚 ESOP on 04/25/2025.

No derivative securities were reported. The filing reflects routine equity compensation vesting rather than discretionary market purchases or sales.

Form 4 overview: On 07/02/2025, Alistair N. Sporck, Vice-President of the Contractor Business Unit at Aehr Test Systems (AEHR), reported several equity transactions.

• Restricted Stock Units granted: 9,253 RSUs with quarterly vesting over four years (1/16 per quarter) and 2,276 RSUs with 25% immediate vesting and the balance vesting quarterly over three years. Both grants were recorded at a cost basis of $0.
• Tax-withholding transaction: 305 shares were automatically withheld at $15.13 to cover taxes on vested RSUs; this is classified as a disposition code 鈥淔鈥� and does not represent an open-market sale.
• Post-transaction ownership: Sporck now directly owns 34,120 common shares and indirectly controls 3,993 shares through a trust.
• The filing notes an additional 936 shares received on 04/25/2025 from the termination of the company鈥檚 ESOP, included in the total.

No derivative securities were reported. The transactions reflect routine executive compensation and tax-withholding activity, with no cash proceeds to the insider and no change to the company鈥檚 share count.